Epirubicin cancer drug

Product Description

Epirubicin is used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. Epirubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.

Oncology-Grade Potency and Spectrum

Epirubicin offers robust efficacy against an array of solid tumors, including breast, ovarian, gastric, and lung cancers. Its formulation as an anthracycline cytotoxic antibiotic ensures a broad antitumor spectrum. Produced under strict USP/EP/BP standards, each vial delivers a reliable, ready-to-use dose for tailored chemotherapy regimens in clinical oncology practice.


Proper Handling and Safe Administration

Administered by intravenous (IV) infusion or intravesical instillation, Epirubicin injections must be managed by qualified medical professionals. The drug is presented as a sterile, single-use glass vial in red-orange, clear solution form. Strict adherence to compatibility guidelines and monitoring protocols helps ensure patient safety and optimal therapeutic results.


Comprehensive Storage and Shelf Life Guidelines

Epirubicin Hydrochloride Injection must be stored at 2C to 8C and protected from light to preserve stability and efficacy. The shelf life of this oncology agent is 24 months. Proper handling and storage are vital to maintain the drug's pharmacological integrity and ensure patient safety during cancer treatment.